1. Home
  2. ANIP vs HMN Comparison

ANIP vs HMN Comparison

Compare ANIP & HMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIP
  • HMN
  • Stock Information
  • Founded
  • ANIP 2001
  • HMN 1945
  • Country
  • ANIP United States
  • HMN United States
  • Employees
  • ANIP N/A
  • HMN N/A
  • Industry
  • ANIP Biotechnology: Pharmaceutical Preparations
  • HMN Property-Casualty Insurers
  • Sector
  • ANIP Health Care
  • HMN Finance
  • Exchange
  • ANIP Nasdaq
  • HMN Nasdaq
  • Market Cap
  • ANIP 2.0B
  • HMN 1.7B
  • IPO Year
  • ANIP N/A
  • HMN 1991
  • Fundamental
  • Price
  • ANIP $90.08
  • HMN $45.10
  • Analyst Decision
  • ANIP Strong Buy
  • HMN Buy
  • Analyst Count
  • ANIP 9
  • HMN 5
  • Target Price
  • ANIP $82.89
  • HMN $46.75
  • AVG Volume (30 Days)
  • ANIP 696.2K
  • HMN 251.8K
  • Earning Date
  • ANIP 08-08-2025
  • HMN 08-06-2025
  • Dividend Yield
  • ANIP N/A
  • HMN 3.12%
  • EPS Growth
  • ANIP N/A
  • HMN 71.62
  • EPS
  • ANIP N/A
  • HMN 3.38
  • Revenue
  • ANIP $747,399,000.00
  • HMN $1,649,200,000.00
  • Revenue This Year
  • ANIP $31.40
  • HMN $7.82
  • Revenue Next Year
  • ANIP $7.38
  • HMN $5.81
  • P/E Ratio
  • ANIP N/A
  • HMN $13.30
  • Revenue Growth
  • ANIP 38.68
  • HMN 6.01
  • 52 Week Low
  • ANIP $52.50
  • HMN $33.00
  • 52 Week High
  • ANIP $91.01
  • HMN $45.36
  • Technical
  • Relative Strength Index (RSI)
  • ANIP 80.26
  • HMN 66.60
  • Support Level
  • ANIP $85.44
  • HMN $44.25
  • Resistance Level
  • ANIP $68.18
  • HMN $45.27
  • Average True Range (ATR)
  • ANIP 3.40
  • HMN 0.90
  • MACD
  • ANIP 1.96
  • HMN 0.27
  • Stochastic Oscillator
  • ANIP 96.69
  • HMN 94.02

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

Share on Social Networks: